Sotera Health Company Q1 2026 Earnings Call Summary

Sotera Health reported mixed performance across its segments in Q1 2026. Sterigenics saw growth driven by pricing and volume/mix, while Nordion's revenue increase was due to Cobalt-60 harvest timing rather than market shifts. Nelson Labs remained stable amid ongoing challenges from the Expert Advisory Services business.

By Moby Intelligence Tue, May 5, 2026 at 7:52 PM GMT+3 3 min read · Yahoo Finance ·

Sotera Health Company Q1 2026 Earnings Call Summary

Tickers: $SHC

Topics: Earnings Legal Milestone Operational Performance Revenue Growth Strategic Guidance

Read the full article at Yahoo Finance

More World news